�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
"the drug must be administered at the right time point during development," he said.
.